The European Medicines Agency’s appeal in its clash with landlord Canary Wharf Group, over the impact of Brexit on its £13m-a-year lease, may not be heard for close to a year. The Court of Appeal has tentatively listed the appeal
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
Register
Find Out More